[HTML][HTML] Botulinum Toxin for the Treatment of Raynaud's Conditions of the Hand: Clinical Practice Updates and Future Directions

P O'Donohoe, J McDonnell, J Wormald, L Aljohmani… - Toxins, 2024 - mdpi.com
Raynaud's conditions of the hand, referred to commonly as Raynaud's phenomenon, both
primary and secondary, represents a spectrum of disorders affecting the digits, characterised …

Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy

M Yan, Z Wang, Z Qiu, Y Cui, Q **ang - Biomarker Research, 2024 - Springer
Platelets are essential for blood clotting and maintaining normal hemostasis. In pathological
conditions, platelets are increasingly recognized as crucial regulatory factors in various …

Impact of pain and adverse health outcomes on long-term US testicular cancer survivors

PC Dinh Jr, PO Monahan, SD Fosså… - JNCI: Journal of the …, 2024 - academic.oup.com
Background No study has quantified the impact of pain and other adverse health outcomes
on global physical and mental health in long-term US testicular cancer survivors or …

Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health

RA Kloner, AL Burnett, M Miner… - The Journal of …, 2024 - academic.oup.com
Background In 1999, 1 year after the approval of the first oral phosphodiesterase type 5
(PDE5) inhibitor for the treatment of erectile dysfunction (ED), the first Princeton Consensus …

Primary antibody deficiency-associated arthritis shares features with spondyloarthritis and enteropathic arthritis

NM Pott, F Atschekzei, CC Pott, D Ernst, T Witte… - RMD open, 2022 - rmdopen.bmj.com
Objective The clinical spectrum of primary antibody deficiencies (PADs) and especially
common variable immunodeficiency (CVID) includes various autoimmune disorders. We …

Genetic and functional analysis of Raynaud's syndrome implicates loci in vasculature and immunity

A Tervi, M Ramste, E Abner, P Cheng, JM Lane… - Cell genomics, 2024 - cell.com
Raynaud's syndrome is a dysautonomia where exposure to cold causes vasoconstriction
and hypoxia, particularly in the extremities. We performed meta-analysis in four cohorts and …

The α2A-adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud's syndrome

A Tervi, M Ramste, E Abner, P Cheng, JM Lane… - Medrxiv, 2023 - medrxiv.org
Raynaud's syndrome is a common dysautonomia where exposure to cold increases the
vascular tone of distal arteries causing vasoconstriction and hypoxia, particularly in the …

Botulinum toxin for Raynaud's phenomenon: A decade of real-world evidence

EL Pinto-Pulido, I Polo-Rodríguez… - Journal of the American …, 2025 - Elsevier
In the last few years, the improvement of Raynaud's phenomenon (RP) with botulinum toxin
(BT) 2 has been described. However, studies include a limited number of patients and follow …

12. Vascular pain: Ischemic pain in the extremities and Raynaud's syndrome

A van Der Gaag, SP Cohen, MP Stojanovic… - Pain …, 2025 - Wiley Online Library
Introduction Peripheral artery diseases (PAD) and Raynaud's syndrome are associated with
substantial morbidity. PAD, through the restriction of blood flow to the extremities, may lead …

[BOOK][B] BUKU AJAR ILMU KARDIOVASKULAR Berbasis Standar Nasional Pendidikan Profesi Dokter Jilid 2

IGR Suryawan - 2024 - books.google.com
Buku ini melengkapi buku penulis yang lebih dahulu terbit yaitu Buku Ajar
Kegawatdaruratan Kardiovaskular Berbasis Standar Nasional Pendidikan Profesi Dokter …